Abeona Therapeutics Inc.
ABEO
$6.91
-$0.04-0.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 400.00K | -- | -- | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.00K | -- | -- | 0.00 | 0.00 |
| Cost of Revenue | 49.77M | 52.95M | 50.22M | 47.26M | 47.14M |
| Gross Profit | -49.37M | -52.95M | -50.22M | -47.26M | -47.14M |
| SG&A Expenses | 41.02M | 32.51M | 29.85M | 28.00M | 25.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.94M | 69.61M | 64.21M | 60.75M | 56.74M |
| Operating Income | -74.54M | -69.61M | -64.21M | -60.75M | -56.74M |
| Income Before Tax | 72.75M | -44.19M | -63.73M | -71.03M | -52.60M |
| Income Tax Expenses | 15.51M | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.24 | -44.19 | -63.73 | -71.03 | -52.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.24M | -44.19M | -63.73M | -71.03M | -52.60M |
| EBIT | -74.54M | -69.61M | -64.21M | -60.75M | -56.74M |
| EBITDA | -72.43M | -67.56M | -62.21M | -58.79M | -54.75M |
| EPS Basic | 1.01 | -0.88 | -1.79 | -2.25 | -2.09 |
| Normalized Basic EPS | -1.00 | -0.55 | -1.12 | -1.40 | -1.31 |
| EPS Diluted | 0.64 | -1.32 | -2.24 | -2.69 | -2.54 |
| Normalized Diluted EPS | -0.93 | -0.57 | -1.14 | -1.43 | -1.33 |
| Average Basic Shares Outstanding | 199.07M | 186.55M | 164.09M | 141.10M | 117.82M |
| Average Diluted Shares Outstanding | 213.18M | 197.77M | 175.30M | 152.32M | 129.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |